The 22nd China International In Vitro Diagnostic Expo by CACLP will take place from 22-24 March 2025 at the Hangzhou Grand Convention & Exhibition Center in Hangzhou, China, alongside a range of concurrent activities starting from 21 March to enhance the overall event experience.

Taking place 22-24 March at the Hangzhou Grand Convention & Exhibition Center, CACLP 2025—the 22nd China International In Vitro Diagnostic Expo—will make a significant impact, bringing a sharp focus to global innovation and industry collaboration. With the theme "Innovation for a Better Future", the event is set to bring together industry leaders and emerging players. The preliminary exhibitor list features an impressive range of global participants, ready to showcase cutting-edge advancements and connect with local resources in China’s fast growing in vitro diagnostics (IVD) market.

Organized by Broad (Shanghai) Exhibition Business Co., Ltd., CACLP Expo 2019 is going to be hosted from March 20 th to 24 th at Nanchang Greenland International Expo Center. Again it`s the annual get-together time for our IVD industry, again

NEW YORK (GenomeWeb) Bruker said on Thursday that it has acquired Berlin-based JPK Instruments for an undisclosed amount. JPK provides microscopy instrumentation for biomolecular and cellular imaging, as well as force measurements on single

雅培Q2有机Dx收入增长7％Abbott Q2 Organic Dx Revenues Rise 7 Percent Abbott recentlysaid that its Diagnostics business revenues grew 47 percent year over year in the second quarter, driven by sales in its rapid diagnostics business,

PerkinElmer与Enzyvant合作开发法伯病诊断测试 专注罕见病创新性疗法开发的生物医药公司Enzyvant近日宣布，它已与PerkinElmer合作，为患者及其医疗服务提供者提供法伯病的诊断测试。 通过

安捷伦完成对ULTRA Scientific的收购Agilent Completes Acquisition of ULTRA Scientific 近日，安捷伦科技公司宣布，它已完成对ULTRA Scientific公司业务资产的收购，该公司是化学标准品和认证标准物质的

Company: lumigenex Website: www.lumigenex.com Product: Time-resolved Fluorescence Immunoanalyzer

On February 7, 2014, China Food and Drug Administration (CFDA) issued the Special Review and Approval Procedure for Innovative Medical Devices (interim), which will be put into force as of March 1, 2014. The Procedure is an approval channel for innova

ChapterIGeneralProvisions Article1 TheseRegulationsareherebyformulatedwithaviewtostrengtheningthesupervisionandadministration ofmedicaldevices,ensuringtheirsafetyandeffectivenessandprotectinghumanhealthandlifesafety. Article2 Allunitsorindi